SCHOTT Pharma AG & Co. KGaA header image

SCHOTT Pharma AG & Co. KGaA

1SXP

Equity

ISIN DE000A3ENQ51 / Valor 128964250

Xetra (2026-03-24)
EUR 13.30+1.84%

SCHOTT Pharma AG & Co. KGaA
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

SCHOTT Pharma AG & Co. KGaA, a subsidiary of SCHOTT AG, specializes in the production of drug containment and delivery systems, including pharmaceutical syringes, cartridges, vials, and ampoules. With a global presence in 34 countries and 16 GMP-compliant manufacturing sites, the company produces over 13 billion drug containers annually, catering to the needs of the pharmaceutical industry. Employing more than 4,700 professionals across North America, Europe, Asia, and Latin America, SCHOTT Pharma collaborates with leading industry partners to ensure the safe, fast, and reliable delivery of medicines. The company operates under the ownership of the Carl Zeiss Foundation and is headquartered in Mainz, Germany. In the fiscal year 2021, SCHOTT Pharma contributed to SCHOTT AG's overall sales of 2.5 billion euros, leveraging its expertise in borosilicate glass and high-grade pharmaceutical COC polymer to meet diverse drug formulation requirements.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-43.6%1Y
%3Y
%5Y

Performance

37.5%1Y
38.6%3Y
38.6%5Y

Volatility

Market cap

2323 M

Market cap (USD)

Daily traded volume (Shares)

69,250

Daily traded volume (Shares)

1 day high/low

25.1 / 24.7

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

bioMerieux SA
bioMerieux SA bioMerieux SA Valor: 38147803
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.18%EUR 90.15
Siemens Healthineers AG
Siemens Healthineers AG Siemens Healthineers AG Valor: 40652181
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.14%EUR 36.71
Fresenius Medical Care AG
Fresenius Medical Care AG Fresenius Medical Care AG Valor: 520878
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.25%EUR 37.94
Evolent Health Inc
Evolent Health Inc Evolent Health Inc Valor: 28153126
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-9.64%USD 2.25
Vita 34 AG
Vita 34 AG Vita 34 AG Valor: 2333201
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.84%EUR 4.78
Maternus-Kliniken AG
Maternus-Kliniken AG Maternus-Kliniken AG Valor: 335800
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-54.01%EUR 1.95
QuidelOrtho Corporation
QuidelOrtho Corporation QuidelOrtho Corporation Valor: 119356965
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.30%USD 16.17
Novartis Inc
Novartis Inc Novartis Inc Valor: 1200526
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.17%CHF 117.48
Savaria Corp
Savaria Corp Savaria Corp Valor: 1385257
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.06%CAD 25.81
Johnson & Johnson
Johnson & Johnson Johnson & Johnson Valor: 943981
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.06%USD 235.27